Sundrug Co.,Ltd.
SDGCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $802 | $752 | $690 | $649 |
| % Growth | 6.7% | 8.9% | 6.4% | – |
| Cost of Goods Sold | $598 | $562 | $4 | $4 |
| Gross Profit | $204 | $189 | $1 | $1 |
| % Margin | 25.5% | 25.2% | 0.2% | 0.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $142 | -$0 | $1 | $1 |
| Sales & Mktg Exp. | $142 | $0 | $0 | $0 |
| Other Operating Expenses | $17 | $148 | $0 | $0 |
| Operating Expenses | $160 | $148 | $1 | $1 |
| Operating Income | $44 | $41 | $37 | $34 |
| % Margin | 5.5% | 5.5% | 5.4% | 5.2% |
| Other Income/Exp. Net | -$1 | $0 | $0 | $1 |
| Pre-Tax Income | $44 | $41 | $38 | $35 |
| Tax Expense | $13 | $12 | $12 | $11 |
| Net Income | $31 | $29 | $26 | $24 |
| % Margin | 3.8% | 3.9% | 3.7% | 3.7% |
| EPS | 262.91 | 249.07 | 219.83 | 204.02 |
| % Growth | 5.6% | 13.3% | 7.7% | – |
| EPS Diluted | 262.91 | 249.07 | 219.82 | 204.01 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $17 | $15 | $12 | $10 |
| EBITDA | $61 | $56 | $50 | $45 |
| % Margin | 7.6% | 7.5% | 7.2% | 6.9% |